We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

LeMaitre Vascular Inc (LMAT) NPV

Sell:$46.80 Buy:$46.88 Change: $1.73 (3.56%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Change: $1.73 (3.56%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Change: $1.73 (3.56%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

LeMaitre Vascular, Inc. is a medical device company. The Company provides medical devices and human tissue cryopreservation services used in the treatment of peripheral vascular disease, end-stage renal disease and cardiovascular disease. It develops, manufactures and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. Its portfolio of devices consists of products that are used in arteries and veins outside of the heart, which includes the LeMaitre valvulotome, the XenoSure biologic patch, the Artegraft collagen vascular graft, the Pruitt F3 carotid shunt, VascuTape radiopaque tape and Syntel embolectomy catheters. Its product line includes Valvulotomes, Surgical Glue, Remote Endarterectomy Devices, Radiopaque Tape, Powered Phlebectomy, ePTFE Vascular Grafts, Polyester Vascular Grafts, Ovine Vascular Grafts, Closure Systems, Carotid Shunts, Allografts, Angioscopes and many others.

Contact details

63 2nd Ave
United States
+1 (781) 2212266

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$1.04 billion
Shares in issue:
21.84 million
Health Care Equipment
United States
US dollar

Key personnel

  • George LeMaitre
    Chairman of the Board, Chief Executive Officer
  • David Roberts
    President, Director
  • Joseph Pellegrino
    Chief Financial Officer, Director
  • Laurie Churchill
    Senior Vice President, General Counsel
  • Andrew Hodgkinson
    Senior Vice President - Clinical, Regulatory, Quality Affairs
  • Trent Kamke
    Senior Vice President - Operations
  • Stephane Maier
    Senior Vice President - EMEA Operations
  • Giovannella Deiure
    Vice President - Sales, Southern Europe
  • Chance Kriesel
    Vice President - Sales, The Americas
  • Kimberly Cieslak
    Vice President - Marketing

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.